等待開盤 07-31 09:30:00 美东时间
0.000
0.00%
Veraxa Biotech shares are trading higher after the company announced the advancement of the bispecific ADC program VXA-222.
07-27 22:56
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects FB Financial Corp. (NYSE:FBK) to post quarterly earnings of $1.15 per share on revenue of $177.99 million after the close, according to data from Be...
07-13 14:35
VERAXA Biotech (VRXA) appointed Carl von Halem as interim chief financial officer, succeeding Torsten Bürgermeister Carl von Halem currently serves as CFO of Xlife Sciences and played a key role in VE...
07-11 04:11
VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE) program. VERAXA has engaged ATUM, a global leader in bioengineering and cell line development, t...
07-02 19:04
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 1% on Wednesday. Shares of Super Micro Computer Inc (NASDAQ:SMCI) fell sharply in pre-market trading after the company announced a proposed offering to fund AI orders. Super Micro announced a series of offerings expec...
06-10 20:03
U.S. stocks were higher, with the Dow Jones gaining over 350 points on Wednesday. GE Vernova shares rose 14.1% after beating estimates and raising sales guidance.
04-22 21:56
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TVTX, BE, IONQ, SANA, RGTI, VACH, AOSL.
04-14 22:16
Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainers include Kodiak Sciences Inc and Precigen Inc.
03-26 22:04
Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voyager" or the "Company") held the general meeting on March 12, 2026 and approved the previously announced business combination (the "Business
03-13 18:05
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG, a leading cancer therapy developer, and Voyager Acquisition Corp., a SPAC targeting healthcare, announced the filing of a registration statement with the SEC regarding their proposed $1.3 billion business combination. VERAXA shareholders will receive approximately 130 million ordinary shares of the combined company, and VERAXA is expected to access $253 million in cash upon closing. The...
2025-07-17 12:55